Presentation is loading. Please wait.

Presentation is loading. Please wait.

Patient case study 2—fibrotic uILD in the setting of IPAF

Similar presentations


Presentation on theme: "Patient case study 2—fibrotic uILD in the setting of IPAF"— Presentation transcript:

1 Patient case study 2—fibrotic uILD in the setting of IPAF
Patient case study 2—fibrotic uILD in the setting of IPAF. CTD, connective tissue disease; DLco, diffusing capacity of the lung for carbon monoxide; FVC, forced vital capacity; HRCT, high-resolution CT; ILD, interstitial lung disease; IPAF, interstitial pne... Patient case study 2—fibrotic uILD in the setting of IPAF. CTD, connective tissue disease; DLco, diffusing capacity of the lung for carbon monoxide; FVC, forced vital capacity; HRCT, high-resolution CT; ILD, interstitial lung disease; IPAF, interstitial pneumonia with autoimmune features; IPF, idiopathic pulmonary fibrosis; MDT, multidisciplinary team; uILD, unclassifiable interstitial lung disease; UIP, usual interstitial pneumonia. Toby M Maher et al. BMJ Open Resp Res 2018;5:e000289 ©2018 by British Thoracic Society


Download ppt "Patient case study 2—fibrotic uILD in the setting of IPAF"

Similar presentations


Ads by Google